基于TCGA数据库分析<em>CDKN2A</em>基因在结肠癌中的表达及其临床意义

doi:10.3969/j.issn.1671-7171.2024.12.006

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (3406 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To analyze the expression level and clinical value of CDKN2A gene in colon cancer based on TCGA database. 【Methods】In this study, TCGA RNA-seq data from the Tumor Immune Evaluation Database (TIMER) were collected to analyze the expression of CDKN2A in colon cancer and the impact of CDKN2A on the prognosis of colon cancer patients. The TIMER database was used to detect the infiltration of immune cells. The correlation between CDKN2A and clinical features was analyzed by R packet, and the protein interaction network information in CDKN2A gene was analyzed by STRING database. 【Results】CDKN2A gene was found to be overexpressed in 16 tumors, especially in colon cancer. The prognosis of colon cancer patients with higher CDKN2A expression level was worse, and the expression level of CDKN2A was significantly correlated with the T stage, N stage and pathological stage of the tumor (P<0.05). ROC curve analysis showed that CDKN2A was more effective in the diagnosis of colon cancer, and the area under the curve was 0.918. CDKN2A and immune checkpoint co-expression showed that CDKN2A was positively correlated with CD274, CTLA4, HAVCR2, LAG3, PDCD1, PDCD1LG2, SIGLEC15 and TIGIT (P<0.05). Spearman correlation analysis showed that CDKN2A expression was positively correlated with CCND1 expression (P<0.05). 【Conclusion】CDKN2A has high efficacy in the diagnosis and prognosis assessment of colon cancer patients, which is a potential target for the treatment of colon cancer, and has important significance in improving the diagnostic accuracy and prognosis assessment of colon cancer.

Key words： Colonic Neoplasms Genes,p16 Databases,Nucleic Acid

Received: 13 May 2024

PACS:

R735.35

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Xinyu
	WANG Guoqing
	GONG Shuangxi

Cite this article:

WANG Xinyu,WANG Guoqing,GONG Shuangxi. The Expression Level and Clinical Value of CDKN2A Gene in Colon Cancer Based on TCGA Database[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(12): 1844-1848.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.12.006 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I12/1844

[1] LIN W W, KARIN M. A cytokine-mediated link between innate immunity, inflammation, and cancer[J].J Clin Invest,2007,117(5):1175-1183.
[2] GUPTA J, DEL B B I, IGEA A, et al. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival[J].Cancer Cell,2014,25(4):484-500.
[3] SLATTERY M L, WOLFF R K, LUNDGREEN A. A pathway approach to evaluating the association between the CHIEF pathway and risk of colorectal cancer[J].Carcinogenesis,2015,36(1):49-59.
[4] SERRA S, CHETTY R. p16: Gene of the month[J].J Clin Pathol,2018,71(10):853-858.
[5] FAROOQ U, SARAVANAN B, ISLAM Z, et al. An interdependent network of functional enhancers regulates transcription and EZH2 loading at the INK4a/ARF locus[J].Cell Rep,2021,34(12):108898.
[6] LI T, FAN J, WANG B, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells[J].Cancer Res,2017,77(21):e108.
[7] SZKLARCZYK D, GABLE A L, NASTOU K C, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets[J].Nucleic Acids Res,2021,49(D1):D605-D612.
[8] SIEGEL R L, MILLER K D, GODING S A, et al. Colorectal cancer statistics, 2020[J].CA Cancer J Clin,2020,70(3):145-164.
[9] ALGABER A, MADHI R, HAWEZ A, et al. Targeting FHL2-E-cadherin axis by miR-340-5p attenuates colon cancer cell migration and invasion[J].Oncol Lett,2021,22(2):637.
[10] ZHANG Y P, DING S, YANG J, et al. Identification of miR-146a is associated with the aggressiveness and suppresses proliferation via targeting CDKN2A in breast cancer[J].Pathol Oncol Res,2020,26(1):245-251.
[11] XIONG G S, LI L Y, CHEN X B, et al. Up-regulation of CKAP2L expression promotes lung adenocarcinoma invasion and is associated with poor prognosis[J].Onco Targets Ther,2019,12:1171-1180.
[12] LI Y F, TSAI W C, CHOU C H, et al. CKAP2L knockdown exerts antitumor effects by increasing miR-4496 in glioblastoma cell lines[J].Int J Mol Sci,2020,22(1):197.
[13] HADER M, STREIT S, ROSIN A, et al. In vitro examinations of cell death induction and the immune phenotype of cancer cells following radiative-based hyperthermia with 915 MHz in combination with radiotherapy[J].Cells,2021,10(6):1436.
[14] ZHANG Q X, VIGNALI D A. Co-stimulatory and co-inhibitory pathways in autoimmunity[J].Immunity,2016,44(5):1034-1051.
[15] HE X, XU C Q. Immune checkpoint signaling and cancer immunotherapy[J].Cell Res,2020,30(8):660-669.
[16] UJIIE H, KADOTA K, NITADORI J I, et al. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers[J].Oncoimmunology,2015,4(6):e1009285.